152 related articles for article (PubMed ID: 36581641)
1. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells.
Jin H; Ladd NA; Peev AM; Swarbrick GM; Cansler M; Null M; Boughter CT; McMurtrey C; Nilsen A; Dobos KM; Hildebrand WH; Lewinsohn DA; Adams EJ; Lewinsohn DM; Harriff MJ
Sci Rep; 2022 Dec; 12(1):22539. PubMed ID: 36581641
[TBL] [Abstract][Full Text] [Related]
2. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
3. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
Elife; 2017 May; 6():. PubMed ID: 28518056
[TBL] [Abstract][Full Text] [Related]
4. Recognition of the antigen-presenting molecule MR1 by a Vδ3
Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Lepore M; Lewinsohn DA; Lewinsohn DM
Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
[TBL] [Abstract][Full Text] [Related]
6. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
Front Immunol; 2020; 11():751. PubMed ID: 32411144
[TBL] [Abstract][Full Text] [Related]
7. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.
Harriff MJ; McMurtrey C; Froyd CA; Jin H; Cansler M; Null M; Worley A; Meermeier EW; Swarbrick G; Nilsen A; Lewinsohn DA; Hildebrand W; Adams EJ; Lewinsohn DM
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 30006464
[TBL] [Abstract][Full Text] [Related]
8. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
McWilliam HEG; Villadangos JA
Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
[TBL] [Abstract][Full Text] [Related]
9. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
10. Production of MR1 Tetramers Loaded with Microbial Ligands.
Ladd NA; Froyd CA; Adams EJ
Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
[TBL] [Abstract][Full Text] [Related]
12. MR1, an immunological periscope of cellular metabolism.
Chancellor A; Vacchini A; De Libero G
Int Immunol; 2022 Feb; 34(3):141-147. PubMed ID: 34718585
[TBL] [Abstract][Full Text] [Related]
13. Atypical TRAV1-2
Awad W; Meermeier EW; Sandoval-Romero ML; Le Nours J; Worley AH; Null MD; Liu L; McCluskey J; Fairlie DP; Lewinsohn DM; Rossjohn J
J Biol Chem; 2020 Oct; 295(42):14445-14457. PubMed ID: 32817339
[TBL] [Abstract][Full Text] [Related]
14. Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments.
Kulicke C; Karamooz E; Lewinsohn D; Harriff M
Front Immunol; 2020; 11():2034. PubMed ID: 32983150
[TBL] [Abstract][Full Text] [Related]
15. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
[TBL] [Abstract][Full Text] [Related]
16. Differential antigenic requirements by diverse MR1-restricted T cells.
Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
[TBL] [Abstract][Full Text] [Related]
17. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
Cornel AM; van der Sman L; van Dinter JT; Arrabito M; Dunnebach E; van Hoesel M; Kluiver TA; Lopes AP; Dautzenberg NMM; Dekker L; van Rijn JM; van den Beemt DAMH; Buhl JL; du Chatinier A; Barneh F; Lu Y; Lo Nigro L; Krippner-Heidenreich A; Sebestyén Z; Kuball J; Hulleman E; Drost J; van Heesch S; Heidenreich OT; Peng WC; Nierkens S
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519054
[TBL] [Abstract][Full Text] [Related]
18. Antigen specificities and functional properties of MR1-restricted T cells.
De Libero G; Chancellor A; Mori L
Mol Immunol; 2021 Feb; 130():148-153. PubMed ID: 33358568
[TBL] [Abstract][Full Text] [Related]
19. Molecular insights into metabolite antigen recognition by mucosal-associated invariant T cells.
Awad W; Ciacchi L; McCluskey J; Fairlie DP; Rossjohn J
Curr Opin Immunol; 2023 Aug; 83():102351. PubMed ID: 37276819
[TBL] [Abstract][Full Text] [Related]
20. The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
Crowther MD; Sewell AK
Curr Opin Immunol; 2021 Apr; 69():10-17. PubMed ID: 33434741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
